ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 98 filers reported holding ENZO BIOCHEM INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,048,000 | +36.6% | 151,002 | +0.2% | 0.00% | 0.0% |
| Q3 2016 | $767,000 | -15.0% | 150,639 | -0.3% | 0.00% | 0.0% |
| Q2 2016 | $902,000 | +3010.3% | 151,049 | +2287.4% | 0.00% | – |
| Q1 2016 | $29,000 | 0.0% | 6,327 | -3.1% | 0.00% | – |
| Q4 2015 | $29,000 | +45.0% | 6,529 | +3.3% | 0.00% | – |
| Q3 2015 | $20,000 | +5.3% | 6,318 | 0.0% | 0.00% | – |
| Q2 2015 | $19,000 | -93.8% | 6,318 | -93.9% | 0.00% | – |
| Q1 2015 | $306,000 | -30.9% | 103,590 | +3.9% | 0.00% | -100.0% |
| Q4 2014 | $443,000 | -13.3% | 99,745 | +0.5% | 0.00% | 0.0% |
| Q3 2014 | $511,000 | +0.2% | 99,281 | +2.3% | 0.00% | 0.0% |
| Q2 2014 | $510,000 | – | 97,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |